Aussie CBD firm MGC Pharmaceuticals and the Royal Melbourne Institute of Technology (RMIT) have recently completed the first stage of development of the digital interface for their database on medicinal cannabis.
Blackmores' practitioner-only firm BioCeuticals is investing heavily in medicinal cannabis research, recently announcing its $500,000-plus funding of the world's first clinical trial to investigate its effects on brain tumours and the symptoms...